The Hidden Epidemic of Smell Loss (Hyposmia) in the United States

Crossmark: check for updates

Authors

  • Robert Henkin Director, The Taste and Smell Clinic, Washington, DC, USA

DOI:

https://doi.org/10.17140/OTLOJ-1-e001

Abstract

There is a hidden epidemic of hyposmia in the United States. While most otolaryngologists may see one or two patients with hyposmia yearly there are as many as 21 million people in the United States with hyposmia. Most of these patients experienced hyposmia following an influenza-like infection.

References

Henkin RI. Report on a survey on smell in the US. Olfact Rev. 1987; 1: 1-8.

Henkin RI, Levy LM, Fordyce A. Taste and smell function in chronic disease: a review of clinical and biochemical evaluation of taste and smell dysfunction in over 5000 patients at The Taste and Smell Clinic in Washington, DC. Am J Otolaryngol. 2013; 34(5): 477-489. doi: 10.1016/j.amjoto.2013.04.006

Henkin RI, Velicu I, Schmidt L. An open-label controlled trial of theophylline for treatment of patients with hyposmia. Am J Med Sci. 2009; 337: 396-406. doi: 10.1097/MAJ.0b013e3181914a97

Henkin RI, Schultz M, Minnick-Poppe L. Intranasal theophylline treatment of hyposmia and hypogeusia: a pilot study. Arch Otolaryngol Head Neck Surg. 2012; 138(11): 1064-1070. doi: 10.1001/2013.jamaoto.342 Otolaryngol Open J Page e2

Downloads

Published

2015-10-12

How to Cite

Robert Henkin. (2015). The Hidden Epidemic of Smell Loss (Hyposmia) in the United States. Otolaryngology, 1(1), e1-e2. https://doi.org/10.17140/OTLOJ-1-e001